心脏衰竭中的生理节奏
Mihail G Chelu1,2,3, Jeanne E Poole4, Kenneth A Ellenbogen5
1Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston.
The New England journal of medicine
|January 21, 2026
概括
心脏再同步疗法 (CRT) 改善了符合条件的患者心力衰竭的结果. 与传统的双心室节奏相比,其他节奏策略,如His捆或左捆分支节奏正在出现,并正在研究它们的有效性.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 电子生理学 电子生理学
背景情况:
- 心脏生理节拍或心脏再同步疗法 (CRT) 是治疗心力衰竭患者的治疗方法,患者的射出分数低,QRS复合体宽.
- 传统的CRT涉及使用右心室导向和冠状动脉鼻导向的双心室节奏.
研究的目的:
- 审查心力衰竭中双心室节奏的确定的益处.
- 引入替代的心脏生理节奏策略,包括他的捆绑和左捆绑分支节奏.
- 突出正在进行的研究,将这些新方法与传统的CRT进行比较.
主要方法:
- 随机试验和最近关于心力衰竭中心脏节奏的研究的综述.
- 对临床结果,运动能力,生活质量和心脏功能的分析 (LVEF,心室体积,心肌回).
主要成果:
- 在超过1万名心力衰竭患者中,双管管节律调节已经显示出显著的临床益处.
- 在患有左束分支阻塞和QRS持续时间≥150毫秒的患者中,益处最为明显.
- 导电系统步调 (其捆绑或左捆绑分支) 正成为一个可行的替代方案.
结论:
- 双动脉节奏仍然是选择心力衰竭患者的基石治疗.
- 导电系统步调提供了一个有希望的替代方案,目前正在进行试验,以确定其比较有效性和安全性.
- 进一步的研究至关重要,以确定个人患者的最佳节奏策略.
更多相关视频
相关概念视频
Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227


